Manila Gyms Are Selling Ozempic to College Kids Who Don't Need It
Drugstores are skipping the prescription. Trainers are pitching weekly shots to 20-year-olds with normal BMI. The diet pill cycle just got an upgrade.
Walk into a boutique gym in BGC or Katipunan and the front desk has a new upsell. Past the protein bars and the BCAA tubs, there's a laminated card or a discreet QR code for a partner clinic offering semaglutide injections. Weekly shots. Package deals. Student promos if you sign up with a friend.
The pitch is not aimed at the people the drug was designed for. It's aimed at 19-year-olds in crop tops who already fit a sample size.
The prescription that isn't
Semaglutide, sold under brand names like Ozempic and Wegovy, was approved for type 2 diabetes and, in higher doses, for obesity. The Philippine FDA classifies it as prescription-only. That's the rule on paper.
On the ground, accounts from young buyers and health workers suggest the gap between rule and counter has widened. Some pharmacies reportedly hand over pens with minimal documentation. Some compounding setups are mixing their own versions. Telehealth platforms can issue scripts after brief online forms that rely largely on self-reported weight.
The buyer is often a college student whose BMI sits squarely in the normal range. The reason given is rarely health. It's a debut, a beach trip, an OOTD season, a thesis defense photo.
Who's actually selling it
The gym is becoming an unofficial referral point. Aesthetic clinics that used to push slimming coffee and IV drips have shifted marketing toward weekly injections. Personal trainers, according to industry observers, sometimes act as the first touchpoint, walking clients toward clinic partners.
The marketing copy is careful. Nobody says weight loss drug. They say metabolic support, appetite regulation, lifestyle reset. The before-and-after photos are pulled from foreign creators. The disclaimers are in font size 6.
Medical groups internationally have raised alarms about off-label semaglutide use in healthy young people, citing risks like rapid muscle loss, gastrointestinal complications, and what online culture has nicknamed Ozempic face, the hollowed look that comes from fast fat loss in places you can't choose. Local doctors have echoed similar concerns in public commentary. Patients don't always tell their physicians they're on it until something goes wrong.
The body politics underneath
The market only works because the demand was already cooked. A generation that grew up with skin whitening ads in every drugstore, K-pop visuals as default attractiveness, and FYPs full of legging hauls is the easiest sell in the world for a thin shot.
The same households that called teenage girls tabachoy at lunch are now helping pay clinic fees. The same gyms that posted body positivity carousels a few years ago are now quietly running injection promos in the back room.
Fat acceptance creators have been saying for years that the Philippine wellness market does not sell health. It sells thinness in whatever delivery system the law has not caught up to yet. Slimming tea. Waist trainers. Saxenda. Now this.
What enforcement looks like
FDA inspections of compounding pharmacies happen, sometimes. Cease and desist letters get issued. Clinics rebrand and reopen in a different mall.
Meanwhile a 20-year-old is injecting a diabetes drug into her stomach every Sunday night because her trainer suggested it would help her cut for summer, and the pharmacy down the street stopped asking questions months ago. The receipt says wellness consultation. The needle says something else.
